Raytheon E-Systems Medical Electronics (E-Med) has named RonaldFord as president and CEO of the San Antonio, TX, teleradiologycompany. Ford replaces James Karlak, who left E-Med in a restructuringin July (SCAN 7/17/96).Ford previously was director of
Raytheon E-Systems Medical Electronics (E-Med) has named RonaldFord as president and CEO of the San Antonio, TX, teleradiologycompany. Ford replaces James Karlak, who left E-Med in a restructuringin July (SCAN 7/17/96).
Ford previously was director of product assurance at the Garland,TX, division of Raytheon E-Systems, where he led the developmentand production of large-scale signal-processing systems. The Garlandunit took over R&D responsibilities for E-Med's PACSPro/DXproduct line as part of the July restructuring, leaving E-Medto concentrate on teleradiology and miniPACS components.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.